4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001104659-20-002254
Options or other derivatives
- Chief Medical Officer acquired 80,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Grachev Igor D Chief Medical Officer | 2020-01-06 | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | D | ||
Loading xslF345X03/tm201560d1_4.xml…